FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, has entered into a new, five year, exclusive distribution agreement with privately-held ST-Medical, based in Athens, Greece, for the distribution of the SonaStar™ Ultrasonic Surgical Aspirator, the BoneScalpel™ Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider. The agreement provides ST-Medical with the rights to sell in Greece and Cyprus, and includes minimum purchase requirements. ST-Medical previously distributed only the SonaStar Ultrasonic Surgical Aspirator.
